Henrik Lund

Direttore/Membro del Consiglio presso Oslo Cancer Cluster NCE

68 anni

Producer Manufacturing

Health Technology

Commercial Services

Profilo

Henrik Lund is currently the Director at Oslo Cancer Cluster NCE and MedCoast Scandinavia.
Previously, he was the Chief Executive Officer and Head-Investor Relations at NEL ASA in 2012 and the CEO and Investor Relations Officer at Bionor Pharma ASA in 2011.

Posizioni attive di Henrik Lund

Società	Posizione	Inizio
Oslo Cancer Cluster NCE Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway.	Direttore/Membro del Consiglio	17/06/2011
MedCoast Scandinavia	Direttore/Membro del Consiglio	17/06/2011

Tutte le posizioni attive di Henrik Lund

Precedenti posizioni note di Henrik Lund

Società	Posizione	Fine
Bionor Pharma ASA Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway.	Presidente	15/08/2011
NEL ASA	Presidente	-

Vedi nel dettaglio l'esperienza di Henrik Lund

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Henrik Lund

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
NEL ASA	Producer Manufacturing

Aziende private	3
Bionor Pharma ASA Bionor Pharma ASA Pharmaceuticals: OtherHealth Technology Bionor Pharma ASA engages in research and development, patenting, and commercialization of products in the pharmaceuticals and biotech industry. The company focuses on the research and development of peptide-based vaccines against viral diseases, primarily HIV. The company was founded on January 2, 1993 and is headquartered in Oslo, Norway.	Health Technology
Oslo Cancer Cluster NCE Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway.	Commercial Services
MedCoast Scandinavia

Vedi le connessioni aziendali